ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody for Chronic Lymphocytic Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00022880
Recruitment Status : Unknown
Verified August 2004 by Corixa Corporation.
Recruitment status was:  Active, not recruiting
First Posted : August 17, 2001
Last Update Posted : June 24, 2005
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by:
Corixa Corporation

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Primary Completion Date : No date given
  Study Completion Date : No date given